Torasemide but not furosemide improves myocardial remodeling in patients with chronic heart failure

被引：0
|
作者：
López, B
Sánchez, E
González, A
Querejeta, R
Larman, M
Querejeta, R
Larman, M
Díez, J
机构：
[1] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain
[2] Donostia Univ Hosp, Div Cardiol, San Sebastian, Spain
[3] Guipuzcoa Policlin, San Sebastian, Spain
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1604
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [21] Effects of Prolonged-Release Torasemide Versus Furosemide on Myocardial Fibrosis in Hypertensive Patients with Chronic Heart Failure: A Randomized, Blinded End Point, Active-Controlled Study
    Anguita, M.
    Castro Beiras, A.
    Cobo, E.
    Coca, A.
    De Teresa, E.
    Diez, J.
    Lopez, B.
    Cebollada, J.
    Diaz, B.
    Galve, E.
    Gonzalez-Juanatey, J. R.
    Jimenez-Navarro, M.
    Lopez, I.
    Lupon, J.
    Martin, C.
    Monserrat, L.
    Narejos, S.
    Pascual Figal, D. A.
    Perez-Calvo, J. I.
    Querejeta, R.
    Ridocci, F.
    Rodriguez, A.
    Rodriguez, M.
    Roig, E.
    Roure, J.
    Ruiz, S.
    Sanchez, P. L.
    Terns, M.
    Toran, P.
    Munoz-Tuduri, Marta
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1204 - 1213
  • [22] Myocardial remodeling and immunologic activation in patients with heart failure
    Rivera, Miguel
    Talens-Visconti, Raquel
    Jordan, Alejandro
    Sirera, Rafael
    Sevilla, Begona
    Climent, Vicente
    Rosello, Esther
    Paya, Rafael
    Cortes, Raquel
    Sancho-Tello, Maria J.
    Valero, Ricardo
    Gonzalez-Molina, Andres
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (09): : 911 - 918
  • [23] Efficiency of torasemide in heart failure in patients with ischemic heart disease and chronic obstructive pulmonary disease
    Knyazkova, I. Irene
    Bilovol, A. N.
    Tsygankov, A. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 337 - 337
  • [24] Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure
    Lopez, Begona
    Gonzalez, Arantxa
    Beaumont, Javier
    Querejeta, Ramon
    Larman, Mariano
    Diez, Javier
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (09) : 859 - 867
  • [25] Torasemide in chronic heart failure:: results of the TORIC study
    Cosín, J
    Díez, J
    EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (04) : 507 - 513
  • [26] COMPARISON OF EFFICACY AND TOLERANCE OF DIFFERENT ORAL DOSES OF TORASEMIDE AND FUROSEMIDE IN PATIENTS WITH ADVANCED CHRONIC RENAL-FAILURE
    KULT, J
    HACKER, W
    GLOCKE, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (1A): : 212 - 214
  • [27] Addition of spironolactone to candesartan improves myocardial strain associated with regression of fibrosis and reverse remodeling in chronic heart failure
    Wang, M.
    Wang, T.
    Chan, A.
    Lam, Y. Y.
    Yip, G.
    Lam, W.
    Yeung, L.
    Yu, C. M.
    Sanderson, J. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 51 - 52
  • [28] Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients A randomized controlled study protocol
    Li, Yifan
    Li, Li
    Guo, Zhipeng
    Zhang, Shunye
    MEDICINE, 2021, 100 (07) : E24661
  • [29] Study of the effects of Prolonged-Release Torasemide on myocardial fibrosis in hypertensive patients with chronic heart failure: design and baseline characteristics
    Gonzalez Juanatey, J. R.
    Anguita, M.
    Coca, A.
    De Teresa, E.
    Diez, J.
    Fernandez, E.
    Castro Beiras, A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 720 - 720
  • [30] PROGNOSTIC IMPORTANCE OF MYOCARDIAL REMODELING PARAMETERS IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE AND ISCHEMIC CARDIOMYOPATHY
    Sisakian, H. S.
    Sanosyan, A. A.
    Sahakyan, L. G.
    Sargsyan, T. M.
    NEW ARMENIAN MEDICAL JOURNAL, 2015, 9 (01): : 27 - 30
12345